Cargando…

Real-world patterns of pegloticase use for treatment of gout: descriptive multidatabase cohort study

OBJECTIVE: Pegloticase is used in severe refractory gout or in cases of intolerance to other urate-lowering therapies. We sought to evaluate the patterns of pegloticase use in the USA and the incidence of safety outcomes. METHODS: We conducted a retrospective descriptive study using data from two US...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Sarah K, Liu, Jun, Kim, Seoyoung C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722814/ https://www.ncbi.nlm.nih.gov/pubmed/33293318 http://dx.doi.org/10.1136/bmjopen-2020-041167

Ejemplares similares

Gout Treatment and Clinical Considerations: The Role of Pegloticase, Colchicine, and Febuxostat
por: Quintana, Michael J, et al.
Publicado: (2023)

New advances in the treatment of gout: review of pegloticase
por: Reinders, Mattheus K, et al.
Publicado: (2010)

Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study
por: Chuang, Jen-Pin, et al.
Publicado: (2019)

Gout and hearing impairment in the elderly: a retrospective cohort study using the US Medicare claims data
por: Singh, Jasvinder A, et al.
Publicado: (2018)

Critical appraisal of the role of pegloticase in the management of gout
por: Ea, Hang-Korng, et al.
Publicado: (2012)

Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
por: Baxter, Britni, et al.
Publicado: (2023)

Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study
por: Chen, Sarah K, et al.
Publicado: (2019)

Gout and the risk for incident heart failure and systolic dysfunction
por: Krishnan, Eswar
Publicado: (2012)

Role of Dual Energy Computed Tomography Imaging in the Diagnosis of Gout
por: Jayakumar, Divya, et al.
Publicado: (2017)

Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study
por: Edwards, Christopher John, et al.
Publicado: (2012)

Long-term safety of pegloticase in chronic gout refractory to conventional treatment
por: Becker, Michael A, et al.
Publicado: (2013)

Randomised controlled trial targeting habit formation to improve medication adherence to daily oral medications in patients with gout
por: Fontanet, Constance P, et al.
Publicado: (2021)

Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout
por: Zhu, Weifeng, et al.
Publicado: (2018)

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review
por: Luttropp, Karin, et al.
Publicado: (2019)

Impact of pegloticase on patient outcomes in refractory gout: current perspectives
por: Cunha, Rita N, et al.
Publicado: (2018)

Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial
por: Lamb, Kirstie Louise, et al.
Publicado: (2020)

Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
por: Fatoye, F, et al.
Publicado: (2019)

Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis
por: Zhang, Yi, et al.
Publicado: (2016)

Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis
por: Yin, Rulan, et al.
Publicado: (2018)

Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry
por: Rahman, Proton, et al.
Publicado: (2017)

What factors contribute to uncontrolled gout and hospital admission? A qualitative study of inpatients and their primary care practitioners
por: Kong, Darren Chyi Hsiang, et al.
Publicado: (2019)

Effectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomised controlled trial protocol
por: Day, Richard O, et al.
Publicado: (2017)

Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis
por: Morillon, Melanie B, et al.
Publicado: (2016)

A Case Report of Successful Management of Refractory Polyarticular Gout With Pegloticase
por: Alnabwani, Dina, et al.
Publicado: (2022)

Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study
por: Andreasen, Rikke Asmussen, et al.
Publicado: (2017)

Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study
por: Goldfien, Robert D, et al.
Publicado: (2014)

Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis
por: Li, Mengtao, et al.
Publicado: (2020)

Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland
por: Burkard, Theresa, et al.
Publicado: (2022)

Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study
por: Balasubramaniam, Gowrie, et al.
Publicado: (2017)

Multidatabases in Health Care systems
por: Bell, D A
Publicado: (1993)

Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study
por: Masri, Karim Richard, et al.
Publicado: (2022)

Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy
por: Baraf, Herbert S. B., et al.
Publicado: (2014)

Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout
por: Broadwell, Aaron, et al.
Publicado: (2022)

Treatment patterns and control of hypertension in systemic lupus erythematosus (SLE): a cross-sectional study
por: Liu, Jia Li, et al.
Publicado: (2021)

Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response
por: Botson, John K., et al.
Publicado: (2022)

Optimizing Reliability of Real-Time Sonographic Examination and Scoring of Joint Synovitis in Rheumatoid Arthritis
por: Ranganath, Veena K, et al.
Publicado: (2022)

Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts
por: Kiely, Patrick, et al.
Publicado: (2019)

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
por: Lipsky, Peter E, et al.
Publicado: (2014)

Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases
por: Morton, Allan H., et al.
Publicado: (2018)

Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout
por: Calabrese, Leonard H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vi2ur45a8g40canmrf47cs23lc